Driving influence across the health care ecosystem
With the biopharmaceutical industry now under extreme pressure to deliver superior medical outcomes while simultaneously reigning in costs and reducing excessive spending, the time is right for Medical Affairs organizations to earn their place at the leadership table by creating opportunities to deliver new value for both patients and the health care ecosystem. This practice perspective provides a four-pillar framework that will operationalize a Medical Affairs organization.
Biopharmaceutical companies are aggressively pursuing strategies to remain competitive by developing and marketing innovative products. At the same time both the cost and practice of medicine are coming under increased scrutiny. With the needs of the health care system continuing to evolve, it has never been more important for companies to proactively demonstrate the impact of their treatments across a broader set of stakeholders.